PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS, SUBGROUP ANALYSIS FROM BRUIN WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT

Overview of attention for article published in Hematological Oncology, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 5 X users

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,563 followers.

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.